BVF INC/IL - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$6,741,000
-58.1%
5,185,383
+11.3%
0.88%
-37.6%
Q3 2018$16,071,000
-15.1%
4,658,353
+12.0%
1.41%
-23.6%
Q2 2018$18,921,000
+39.6%
4,158,353
+1.3%
1.85%
+34.4%
Q1 2018$13,550,000
+136.4%
4,106,200
+179.4%
1.37%
+98.8%
Q4 2017$5,732,000
-31.7%
1,469,800
+19.1%
0.69%
-51.6%
Q1 2017$8,391,000
+15.6%
1,233,976
-6.5%
1.43%
-2.2%
Q4 2016$7,261,000
-20.2%
1,320,164
+10.0%
1.46%
-14.9%
Q3 2016$9,096,0001,200,0001.71%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2016
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders